China Pharma Announces $5 Million Registered Direct Offering
China Pharma Holdings (NYSE American: CPHI) has priced a registered direct offering of 2.5 million shares at $2 per share, raising gross proceeds of $5 million before fees and expenses. The funds will be used for working capital and general corporate purposes.
Tickers: $CPHI
Topics: capital raising equity offering